Ferguson A, Humphreys K A, Croft N M
University of Edinburgh Department of Medicine, Western General Hospital, UK.
Clin Exp Immunol. 1995 Jan;99(1):70-5. doi: 10.1111/j.1365-2249.1995.tb03474.x.
Clinical investigation of gut immunity is difficult because of the need to study intestinal tissues or secretions directly. Others have reported that immunoglobulins, antibodies and cytokines can be detected in saline extracts of faeces. We have assessed the validity of this approach by measuring immunoglobulins, albumin, alpha 1-antitrypsin and isotype-specific antibodies in matched samples of faeces and whole gut lavage fluid. Results were compared as estimated output per day, and by using haemoglobin as a common reference substance. Samples were obtained from 10 patients with active inflammatory bowel disease and 10 with other benign GI diseases. For immunoglobulins, albumin and antibodies, the amount detected in faeces varied from < 0.01% to 35.5% (based on estimated daily output) and < 0.01% to 18.5% (based on haemoglobin) of the amount known to be produced in the gut from results of assays on whole gut lavage fluid (WGLF); there were significantly higher rates of recovery in faecal specimens from patients with active gut inflammation than from other patients. Detection rates and titres of specific antibody in faeces were even lower than those for immunoreactive IgA. These data indicate that immunological tests on saline extracts of faeces do not represent the true status of the gut humoral immune system, and such studies should be strongly discouraged.
由于需要直接研究肠道组织或分泌物,肠道免疫的临床研究存在困难。其他人报告称,粪便盐水提取物中可检测到免疫球蛋白、抗体和细胞因子。我们通过测量粪便和全肠道灌洗液匹配样本中的免疫球蛋白、白蛋白、α1-抗胰蛋白酶和同种型特异性抗体,评估了这种方法的有效性。结果以每日估计产量进行比较,并以血红蛋白作为共同参考物质。样本取自10例活动性炎症性肠病患者和10例其他良性胃肠道疾病患者。对于免疫球蛋白、白蛋白和抗体,粪便中检测到的量占全肠道灌洗液(WGLF)检测结果中已知肠道产生量的<0.01%至35.5%(基于每日估计产量)和<0.01%至18.5%(基于血红蛋白);活动性肠道炎症患者粪便标本中的回收率明显高于其他患者。粪便中特异性抗体的检出率和滴度甚至低于免疫反应性IgA。这些数据表明,对粪便盐水提取物进行免疫检测并不能代表肠道体液免疫系统的真实状态,应强烈反对进行此类研究。